Amy Byler
Medical · Grand Rapids, MINPI 1891005377
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.0% of the total across 340 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 31.0% of the total. 2025 is the largest year on record at $2,844, more than ten times the $75 reported in 2021. Among medical clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 340 payments — averaging $18.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$1K
- Novartis$605
- Johnson & Johnson$568
- AstraZeneca$436
- UCB, Inc.$311
- plus $1K from 16 others
What the payments were for
- Food & beverage$5,98396%
- Education$2514%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 122 | $1,932 |
| Amgen | 68 | $1,132 |
| Novartis | 37 | $605 |
| Johnson & Johnson | 33 | $568 |
| AstraZeneca | 15 | $436 |
| UCB, Inc. | 9 | $311 |
| Fresenius Kabi USA, LLC | 9 | $241 |
| Organon | 14 | $171 |
| Lilly USA, LLC | 4 | $102 |
| Boehringer Ingelheim | 5 | $101 |
| Pfizer | 4 | $85 |
| Bioventus LLC | 3 | $84 |
| Aspira Women's Health Inc | 1 | $75 |
| E.r. Squibb & Sons, L.L.C. | 2 | $74 |
| Sanofi | 3 | $71 |
| Sobi, Inc | 3 | $70 |
| Sandoz | 3 | $64 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 |
| Celltrion USA Inc. | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Invivyd Inc | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$130
How this compares
$6,234 in reported general payments places this provider in the 90th percentile of 755 medical providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 12 | $81,051 |
| Hydroxychloroquine Sulfate | 58 | $2,243 |
| Prednisone | 69 | $438 |
| MethotrexateMethotrexate Sodium | 31 | $315 |
| Folic Acid | 14 | $32 |
Paid to pharmacies, not to this prescriber.
Other medical in Grand Rapids
- Meredith KentGrand Rapids$192K
- David BarneyGrand Rapids$21K
- Nisha McKenzieGrand Rapids$19K
- Brenda WhartonGrand Rapids$11K
- Andra TalaskaGrand Rapids$11K
- Jennifer DykhouseGrand Rapids$8K
- Evan GerondaleGrand Rapids$7K
- Caleb YoungbloodBerkley$215K
- Steven StoneKalamazoo$200K
- Amber ShullNorton Shores$154K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.